XT
CALC icon

XTX Topco’s CalciMedica CALC Stock Holding History

XTX Topco’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,345
Closed -$46.3K – 3354
2025
Q3 		$46.3K Buy
+15,345
New +$44.1K ﹤0.01% 2188
2021
Q2 		– Sell
-1,002
Closed -$78K – 830
2021
Q1 		$78K Buy
+1,002
New +$300K 0.04% 589

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

XTX Topco's CALC Position: Q4 2025 in Review

XTX Topco sold out of CalciMedica (CALC) in Q4 2025, closing a stake of 15,345 shares — an estimated $46.3K sold.

XTX Topco first reported a position in CALC in Q1 2021 and held it in 2 quarters. The position peaked at $78K in Q1 2021. 30 funds tracked by Wall St. Rank hold CALC as of Q4 2025.

  • XTX Topco reported no remaining CalciMedica position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 15,345 CalciMedica shares in Q4 2025, an estimated $46.3K.
  • XTX Topco first reported a position in CalciMedica in Q1 2021 and held it in 2 quarters.
  • XTX Topco's CalciMedica position peaked at $78K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.